Page last updated: 2024-12-06

2-aminoethylmethacrylate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2-Aminoethylmethacrylate (AEMA) is a bifunctional monomer containing both a methacrylate group and a primary amine group. Its synthesis typically involves the reaction of methacrylic acid with 2-aminoethanol. AEMA is a valuable monomer used in the preparation of various polymers with unique properties, particularly for biomedical applications. Its amine functionality enables the introduction of various functionalities through reactions with different chemical groups. This allows for the development of polymers with tailored properties, such as improved biocompatibility, degradability, and drug delivery capabilities. AEMA-based polymers have been investigated for applications such as tissue engineering, drug delivery systems, and biocompatible coatings. The presence of the amine group in AEMA allows for its conjugation to biomolecules, such as peptides and proteins, enhancing its bioactivity. Furthermore, AEMA polymers can be crosslinked to form hydrogels with tunable properties, offering potential for applications in regenerative medicine and wound healing. The biocompatibility and functional versatility of AEMA make it a promising building block for the development of new materials with diverse applications in the biomedical field.'

aminoethyl methacrylate: cell-adhesive dextran hydrogel [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID75496
CHEBI ID187917
SCHEMBL ID69712
MeSH IDM0196823

Synonyms (16)

Synonym
z4jsa65hua ,
2-propenoic acid, 2-methyl-, 2-aminoethyl ester
unii-z4jsa65hua
2-aminoethylmethacrylate
2-aminoethyl methacrylate
2-aminoethyl 2-methylprop-2-enoate
CHEBI:187917
7659-36-1
AKOS006221870
SCHEMBL69712
DTXSID60227392
aminoethyl methacrylate
2-(amino)ethylmethacrylate
AM10040
CS-0455657
EN300-4257766

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
"56% with contact time and membrane dosage respectively while decreased from 99."( Application of QPPO/PVA based commercial anion exchange membrane as an outstanding adsorbent for the removal of Eosin-B dye from wastewaters.
Alfantazi, AM; Alsaiari, M; Anwer, R; Faisal, M; Farooq, N; Harraz, FA; Khan, MI; Lashari, MH; Manzoor, S; Shanableh, A, 2023
)
0.91
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
enoate esterAn alpha,beta-unsaturated carboxylic ester of general formula R(1)R(2)C=CR(3)-C(=O)OR(4) (R(4) =/= H) in which the ester C=O function is conjugated to a C=C double bond at the alpha,beta position.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (61)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (1.64)18.2507
2000's6 (9.84)29.6817
2010's36 (59.02)24.3611
2020's18 (29.51)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.56

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.56 (24.57)
Research Supply Index4.14 (2.92)
Research Growth Index5.70 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.56)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (3.23%)6.00%
Case Studies1 (1.61%)4.05%
Observational0 (0.00%)0.25%
Other59 (95.16%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]